Home About Cancer News Contact Cancer News
Home About Cancer News Contact Cancer News
Twitter

TACE Combinated With Sorafenib in Treating Patients With Unresectable Hepatocellular Carcinoma

by on Friday, May 25th, 2012 | No Comments

Conditions:   PHENYTOIN/SORAFENIB [VA Drug Interaction];   Carcinoma, Hepatocellular
Interventions:   Procedure: TACE;   Drug: sorafenib combined with TACE
Sponsors:   Shandong Cancer Hospital and Institute;   Shandong Cancer Hospital and Institute
Not yet recruiting – verified May 2012

Read the original here: TACE Combinated With Sorafenib in Treating Patients With Unresectable Hepatocellular Carcinoma



Tags: , , , , , , , , , , ,
Posted in Cancer Clinical Trials

Comments are closed.